Postmarket Outcomes Study for Evaluation of the Superion™ Spacer

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

March 20, 2023

Study Completion Date

March 20, 2023

Conditions
Lumbar Spinal Stenosis
Interventions
DEVICE

Superion™ IDS

All patients to receive IDS for the treatment of moderate Lumbar Spinal Stenosis symptoms.

Trial Locations (23)

19010

Center for Interventional Pain and Spine, Bryn Mawr

30265

Georgia Pain and Spine Care, Inc., Newnan

31501

Centurion Spine and Pain Centers, Waycross

32953

Florida Pain Institute, Merritt Island

33308

Holy Cross Hospital Inc., Fort Lauderdale

33477

Louis J. Raso, MD, PA, Jupiter

33948

Southwest Florida Pain Center, Port Charlotte

43623

The Toledo Clinic, Toledo

60612

Rush University Medical Center, Chicago

64086

KC Pain Centers, Lee's Summit

66160

University of Kansas Hospital, Kansas City

75701

Precision Spine Care, Tyler

78041

Advanced Spine Pain Solution, Laredo

83854

North Idaho Day Surgery LLC, Post Falls

89052

Comprehensive and Interventional Pain Management LLP, Henderson

90403

Source Healthcare, Santa Monica

92103

Relieve Pain Center, Inc., San Diego

92708

Pain Medicine Associates, Fountain Valley

94598

IPM Medical Group Inc, Walnut Creek

94939

California Orthopedics & Spine, Larkspur

95403

Pacific Research Institute, Santa Rosa

07702

Premier Pain Center, Shrewsbury

08873

University Clinical Research Center, Somerset

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY